Related Experiment Video

Updated: Jul 16, 2026

Murine Oropharyngeal Aspiration Model of Ventilator-associated and Hospital-acquired Bacterial Pneumonia
04:32

Murine Oropharyngeal Aspiration Model of Ventilator-associated and Hospital-acquired Bacterial Pneumonia

Published on: June 28, 2018

[Ventilator-associated pneumonia and multiresistant bacteria]

Alexandra Heininger1, Klaus Unertl

  • 1Klinik für Anästhesiologie und Intensivmedizin der Universität Tübingen, Germany. alexandra.heininger@med.uni-tuebingen.de

Anasthesiologie, Intensivmedizin, Notfallmedizin, Schmerztherapie : AINS
|February 20, 2007
PubMed

Insights

Prompt antibiotic therapy is crucial for treating ventilator-associated pneumonia (VAP). Tailor empirical treatment based on multiresistant bacteria risk and discontinue antibiotics after one week to combat resistance.

Area of Science:

  • Critical care medicine
  • Infectious diseases
  • Hospital-acquired infections

Context:

  • Ventilator-associated pneumonia (VAP) is a severe nosocomial infection in intensive care units.
  • Effective management hinges on timely and appropriate antibiotic administration.
  • Diagnostic methods play a secondary role compared to prompt therapeutic intervention.

Purpose:

  • To outline optimal strategies for empirical antibiotic therapy in VAP.
  • To emphasize the importance of risk assessment for multidrug-resistant organisms.
  • To advocate for deescalation and timely discontinuation of antimicrobial treatment.

Summary:

  • Empirical antibiotic therapy for VAP should be guided by the risk of multidrug-resistant bacteria.
  • Combination therapy is recommended for high-risk patients, considering local resistance patterns.
  • Reevaluation based on culture results and a one-week treatment course are essential.

Impact:

  • Optimizing VAP treatment reduces mortality and morbidity.
  • Judicious antibiotic use curtails the development of antibiotic resistance.
  • Implementing evidence-based guidelines improves patient outcomes and resource stewardship.

More Related Videos

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria11:32

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria

Published on: February 23, 2014

Related Concept Videos

Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Mechanical Ventilation II: Invasive Ventilation01:23

Mechanical Ventilation II: Invasive Ventilation

Ventilators are essential medical equipment used to aid patients with respiratory difficulties. Their primary function is to assist or replace spontaneous breathing by providing mechanical ventilation. There are two general classes of mechanical ventilators: negative-pressure and positive-pressure ventilators.
Negative-Pressure Ventilators
Negative-pressure ventilators create a vacuum around the chest or body to draw air into the lungs, simulating breathing. This method does not require an...
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...